Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Tau7.5
Taurine – Forschung
Hilft wahrscheinlich
52 begutachtete Studien
Was die Evidenz sagt
Hilft wahrscheinlich
Taurine scheint in 5 von 6 Studien mit messbaren Effekten zu helfen — die Evidenz tendiert klar ins Positive.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 2010–2026 mit einer typischen Studiengröße von 83 Teilnehmenden.
Basierend auf 52 Studien · 18 Meta-Analysen · 15 RCTs · 18,631 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
5geholfen1unklar· 46 weitere ohne bewertete Effektdaten
Nach Outcome
Endurance & exercise performanceVerbessert die Zeit bis zur Erschöpfung und reduziert oxidative Muskelschäden · 2-4 Wochen · Verbessert die Ausdauer und reduziert trainingsbedingte Schäden · 1-4 Wochen
Überwiegend Mechanismus / Beobachtung14 Studien
Heart & blood pressureSenkt den Blutdruck und unterstützt die kardiale Kontraktilität · 4-8 Wochen
Überwiegend Mechanismus / Beobachtung9 Studien
Therapeutic & clinical
Überwiegend Mechanismus / Beobachtung8 Studien
Safety profile
Überwiegend Mechanismus / Beobachtung8 Studien
Glucose & metabolicVerbesserte Insulinsensitivität · 4-8 Wochen · Verbessert die Glukosetoleranz und die mitochondriale Funktion · 8-12 Wochen
Überwiegend Mechanismus / Beobachtung7 Studien
Inflammation
Überwiegend Mechanismus / Beobachtung6 Studien
Cognitive function
Überwiegend Mechanismus / Beobachtung5 Studien
Weight management
Überwiegend Mechanismus / Beobachtung5 Studien
Depression & mood
Überwiegend Mechanismus / Beobachtung4 Studien
Muscle strength & power
Überwiegend Mechanismus / Beobachtung4 Studien
Longevity & agingMit dem Altern verbundene Vorteile wurden hauptsächlich in Tierstudien beobachtet; Daten zur Langlebigkeit beim Menschen sind vorläufig · Langfristig
Zu wenige bewertete Studien2 Studien
Cholesterol & lipidsSenkt den Blutdruck und unterstützt die kardiale Kontraktilität · 4-8 Wochen
Zu wenige bewertete Studien2 Studien
Vision & eye health
Zu wenige bewertete Studien1 Studie
Skin health
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 30 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
67%
über Studien hinweg
Untersuchte Personen
19k
typische Studie: 83 Personen
Stärkste Designs
33
18 gepoolt, 15 randomisiert
Zeigte Nutzen
83%
5/6 Studien
Wie lange Studien liefen
1–4 Wochen
1
1–3 Monate
1
3+ Monate
1
Untersuchte Populationen
General population3
Individuals at risk of or with metabolic syndrome1
Heart failure patients and healthy individuals1
Athletes1
Aktives Forschungsgebiet
45 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
201020182026
1Meta-AnalyseCited 1×n=552 · large study2025
While individual supplements may offer limited benefits, synergistic combinations may yield greater improvements in performance and comfort.
Li J et al. · Nutrients (2025)
Standardized mean differences (SMDs) and posterior probabilities (P-scores based on Bayesian ranking) were calculated using random-effects and Bayesian models.
Menthol (SMD = -1.83, 95% CI [-3.15, -0.51]; P-score = 71.04%) and taurine (SMD = 0.91, 95% CI [0.08, 1.73]; P-score = 12.75%) demonstrated significant positive effects on endurance.
Menthol energy gel showed the greatest improvement in thermal comfort (SMD = 2.14, 95% CI [1.01, 3.26]; P-score = 99.54%).
2Metabolic syndrome factorsMeta-AnalyseCited 19×n=1,024 · large study2024
Taurine supplementation exhibits positive effects on multiple MetS-related factors, making it a potential dietary addition for individuals at risk of or already experiencing MetS.
Tzang CC et al. · Nutrition & diabetes (2024)
Taurine supplementation exhibits positive effects on multiple MetS-related factors, making it a potential dietary addition for individuals at risk of or already experiencing MetS.
Future research may explore dose-optimization strategies and potential long-term benefits of taurine for MetS management.
4Cognitive functionMeta-AnalyseCited 3×n=402 · medium study2025
Overall, the findings of the present meta-analysis do not provide sufficient evidence to support the efficacy of taurine supplementation in enhancing cognitive function.
Cao Q et al. · International journal of food sciences and nutrition (2025)
A total of 7 RCTs with 9 intervention trials involving 402 individuals were included.
Taurine, administered alone or in combination with exercise training, did not exhibit significant effects in cognitive scores.
Overall, the findings of the present meta-analysis do not provide sufficient evidence to support the efficacy of taurine supplementation in enhancing cognitive function.
CAF+TAU co-supplementation provides a balanced ergogenic effect, combining the central stimulation of CAF with the neuromodulatory and metabolic support of TAU, particularly beneficial for high-intensity, reaction-based tasks.
Deng H et al. · Journal of the International Society of Sports Nutrition (2025)
Posterior estimates indicated that CAF+TAU was associated with a credible positive effect on anaerobic capacity (g = 0.46, 95% CrI [0.19, 0.71]) and reaction time (g = 0.75, 95% CrI [0.29, 1.18]) compared to CAF or TAU alone.
CAF showed the greatest posterior reduction in RPE (g = -0.64, 95% CrI [-1.20, -0.10]), while its posterior mean estimate suggested a potential increase in B[la] (g = 0.24, 95% CrI [-0.48, 0.96]).
In contrast, TAU showed a possible tendency toward reducing B[la] (g = -0.30, 95% CrI [-1.01, 0.42]).
A three-level random-effects meta-analysis indicated that acute taurine ingestion may be associated with small-to-moderate improvements in overall performance (g = 0.25, 95% CI [0.10, 0.39], I2 = 6...
Deng H et al. · Scandinavian journal of medicine & science in sports (2025)
A three-level random-effects meta-analysis indicated that acute taurine ingestion may be associated with small-to-moderate improvements in overall performance (g = 0.25, 95% CI [0.10, 0.39], I2 = 61%).
The overall certainty of evidence, assessed using GRADE, was rated low to very low due to heterogeneity, imprecision, and risk of bias.
Collectively, these findings suggest that acute single-dose taurine supplementation holds promise as an ergogenic aid, but its effectiveness likely varies depending on dosage, blinding procedures, and exercise context.
8Peripheral blood metabolites in major depressive disorderMeta-AnalyseCited 171×n=46 · small study2021
MDD patients were characterized by higher levels of asymmetric dimethylarginine, tyramine, 2-hydroxybutyric acid, phosphatidylcholine (32:1), and taurochenodesoxycholic acid and lower levels of L-acetylcarnitine, creatinine, L-asparagine, L-glutamine, linoleic acid... compared with controls.
Pu J et al. · Molecular psychiatry (2021)
Pathway and network analyses revealed altered amino acid metabolism and lipid metabolism, especially for the tryptophan-kynurenine pathway and fatty acid metabolism, in the peripheral system of MDD patients.
Our findings may facilitate biomarker development and the elucidation of the molecular mechanisms that underly MDD.
Long-term taurine supplementation is particularly effective in improving glycemic control and insulin sensitivity in obesity.
Sun Q et al. · Nutrients (2024)
In the subgroup analysis, long-term taurine intake led to BMI improvement in overweight adults (WMD = -1.14 kg/m2, 95% CI: -1.81 to -0.47, p = 0.0008, I2 = 0%).
Meanwhile, improvements in HbA1c (WMD = -0.33%, 95% CI: -0.53 to -0.12, p = 0.002, I2 = 16%) and HOMA-IR (WMD = -0.91, 95% CI: -1.74 to -0.08, p = 0.003, I2 = 54%) were observed only in obese participants following taurine supplementation.
Additionally, the long-term intake of 3 g of taurine significantly improved HbA1c (WMD = -0.37%, 95% CI: -0.61 to -0.13, p = 0.003, I2 = 0%) and FPG levels (WMD = -7.14 mg/dL, 95% CI: -12.53 to -1.74, p = 0.003, I2 = 70%) in overweight/obesity.
The physiological mechanisms underlying the production of visual fatigue are summarized and the research progress of taurine in relieving visual fatigue is reviewed, including the safety of consumption and the mechanism of action in relieving visual fatigue, in order to provide some reference basis and inspiration for the development and application of taurine in functional foods for relieving visual fatigue.
Duan H et al. · Nutrients (2023)
According to reports, supplementation with appropriate doses of taurine may help to reduce visual fatigue.
Presently, some progress has been made in research related to taurine in eye health, but the lack of systematic summaries has led to the neglect of its application in the relief of visual fatigue.
This paper, therefore, provides a systematic review of the sources of taurine, including the endogenous metabolic and exogenous dietary pathways, as well as a detailed review of the distribution and production of exogenous taurine.
In conclusion, the antihypertensive effect of chronic taurine supplementation shows promise in the treatment of prehypertension through improvement of vascular function.
Sun Q et al. · Hypertension (2016)
Taurine supplementation significantly decreased the clinic and 24-hour ambulatory BPs, especially in those with high-normal BP.
Mean clinic systolic BP reduction for taurine/placebo was 7.2/2.6 mm Hg, and diastolic BP was 4.7/1.3 mm Hg.
In addition, taurine supplementation significantly improved endothelium-dependent and endothelium-independent vasodilation and increased plasma H2S and taurine concentrations.
12Physical performance in female athletesMeta-AnalyseCited 19×2022
More studies are needed in female athletes that measure the effects of different EAs on sports performance, such as beetroot juice, beta-alanine or sodium phosphate, as the studies to date are scarce and there are many types of EA that need to be further considered in this population, such as creatine and taurine.
López-Torres O et al. · Nutrients (2022)
A random-effects model and the standardized mean differences (SMD) ± 95% confidence intervals (CI) were reported.
Aerobic tests could be improved with the use of taurine, caffeine, and beta-alanine.
No conclusive effects of beetroot juice, polyphenols, or creatine in improving aerobic performance were shown.
14C-reactive protein levelsMeta-AnalyseCited 24×2022
Tau can decrease the levels of CRP and MDA.
Faghfouri AH et al. · European journal of clinical nutrition (2022)
Sehr groß Nutzen
← SchlechterKein EffektBesser →
Likely real
Non-linear relationship between variables and effect size was performed using dose-response and time-response analyses.
Tau supplementation can reduce the levels of malondialdehyde (MDA) (SMD = -1.17 µmol/l; 95% CI: -2.08, - 0.26; P = 0.012) and C-reactive protein (CRP) (SMD = -1.95 mg/l; 95% CI: -3.20, - 0.71; P = 0.002).
The taurine dosage varied from 0.5 to 6 g/d for 15 days to 6 months.
Guan L et al. · European journal of pharmacology (2020)
The taurine dosage varied from 0.5 to 6 g/d for 15 days to 6 months.
These findings indicate that, in patients with liver dysregulation, taurine supplementation can lower blood pressure and improve the lipid profile by reducing total cholesterol and triglyceride levels.
Human endurance performance can be improved by orally ingesting a single dose of taurine in varying amounts (1-6 g).
Waldron M et al. · Sports medicine (Auckland, N.Z.) (2018)
Taurine ingestion improved overall endurance performance (Hedges' g = 0.40, 95% CI 0.12-0.67, P = 0.004), which was similar in TTE trials (Hedges' g = 0.43, 95% CI 0.12-0.75, P = 0.007).
There were no differences between acute or chronic supplementation for the full sample (P = 0.897) or the TTE group (P = 0.896).
Human endurance performance can be improved by orally ingesting a single dose of taurine in varying amounts (1-6 g).
Current evidence is promising but remains constrained by small samples and heterogeneous protocols; adequately powered field trials are required to establish dose-response, safety and efficacy across populations, and additive value when combined with established heat-mitigation strategies.
Naddafha S et al. · Nutrients (2026)
Benefits appear to be context-dependent and may be attenuated when sweating is constrained (e.g., impermeable protective clothing) or when heat acclimation is already optimized.
Because taurine may increase sweat losses, its use should be paired with individualized fluid and sodium replacement.
Current evidence is promising but remains constrained by small samples and heterogeneous protocols; adequately powered field trials are required to establish dose-response, safety and efficacy across populations, and additive value when combined with established heat-mitigation strategies.
This review synthesizes current evidence supporting taurine's pleiotropic neuroprotective actions and discusses its translational potential as an early-stage, low-risk intervention to delay or prevent AD progression.
Hossain MK et al. · International journal of molecular sciences (2026)
Growing evidence supports the concept that early, upstream neuroprotective interventions may meaningfully alter disease trajectory in both sporadic and familial AD.
Taurine, an endogenously abundant and clinically safe neuromodulator, has re-emerged as a promising multi-target regulator of AD-relevant pathways.
This review synthesizes current evidence supporting taurine's pleiotropic neuroprotective actions and discusses its translational potential as an early-stage, low-risk intervention to delay or prevent AD progression.
Future research characterized by gender balance and mechanistic orientation with long-term intervention protocols is warranted to elevate the level of clinical evidence.
Yao J, He J, Hu E. · Journal of the International Society of Sports Nutrition (2026)
A three-level random-effects model was employed to calculate the pooled effect size (Hedges' g), with sources of heterogeneity explored through subgroup analyses and meta-regression.
Meta-regression indicated no significant linear correlation between caffeine dosage and effect size.
While the findings exhibit a degree of robustness, their practical application should be cautiously evaluated within specific competitive contexts due to current limitations in evidence certainty and significant interstudy heterogeneity.
We consider results from the different experimental, in vitro studies as well as some clinical ones reviewed, to provide sufficient evidence as to constitute a solid base to back up future clinical and epidemiological studies on the usefulness of taurine supplementation both in the prevention and treatment of diabetes and its complications.
De la Puerta C et al. · Nutricion hospitalaria (2010)